CVE-2023-38956

Name: CVE-2023-38956
Creator: NVD / NIST
Published: 2023-08-03T02:15:09.763+00:00
License: https://creativecommons.org/publicdomain/zero/1.0/

HIGHCVSS 7.5/10EPSS 0.61%

Last modified Jun 17, 2026

CVE-2023-38956 is a high-severity vulnerability rated 7.5/10 on the CVSS scale. A path traversal vulnerability in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload.. EPSS estimates a 0.61% chance of exploitation in the next 30 days.

Description

A path traversal vulnerability in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload.

Metrics

CVSS 3.1

7.5/10

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

EPSS Probability

0.61%

44.6th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

CWE-22

Affected Software

Vendor	Product	Versions
Zkteco	Bioaccess Ivs	3.3.1

References

http://zkteco.comNot Applicable
https://claroty.com/team82/disclosure-dashboard/cve-2023-38956Third Party Advisory
http://zkteco.comNot Applicable
https://claroty.com/team82/disclosure-dashboard/cve-2023-38956Third Party Advisory

Timeline

Published: Aug 3, 2023
Last Modified: Jun 17, 2026
Status: Modified

Frequently Asked Questions

What is CVE-2023-38956?

A path traversal vulnerability in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload.

How severe is CVE-2023-38956?

CVE-2023-38956 has a CVSS score of 7.5/10 (HIGH severity). The EPSS model estimates a 0.61% probability of exploitation in the next 30 days.

How do I fix CVE-2023-38956?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2023-38956?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST